Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q1BE
|
|||
Drug Name |
Pyrrolo[2,3-d]pyrimidine derivative 20
|
|||
Synonyms |
PMID28705083-Compound-18
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
ADVINUS THERAPEUTICS LIMITED
|
|||
Structure |
Download2D MOL |
|||
Formula |
C37H38N6O3
|
|||
Canonical SMILES |
CN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N=CN=C4N3)C5=C(C(=CC=C5)N6CCOC7=C(C6=O)C=CC(=C7)C8CC8)CO
|
|||
InChI |
1S/C37H38N6O3/c1-41-13-15-42(16-14-41)21-24-5-7-26(8-6-24)32-20-30-35(38-23-39-36(30)40-32)28-3-2-4-33(31(28)22-44)43-17-18-46-34-19-27(25-9-10-25)11-12-29(34)37(43)45/h2-8,11-12,19-20,23,25,44H,9-10,13-18,21-22H2,1H3,(H,38,39,40)
|
|||
InChIKey |
AYQKNTPWCXIAQQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors.Expert Opin Ther Pat. 2017 Dec;27(12):1305-1318. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.